V. Bramwell
Impact in
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
- Oncology top 1%
- Vascular Tumors and Angiosarcomas
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 42
- Vascular Tumors and Angiosarcomas 17
- Cancer Treatment and Pharmacology 11
- HER2/EGFR in Cancer Research 4
-
- Sarcoma Diagnosis and Treatment 30
- Co-authors
- Mark N. Levine (13 shared papers)Kathleen I. Pritchard (10 shared papers)Armando Santoro (11 shared papers)J. Buesa (7 shared papers)David Warr (4 shared papers)Lois E. Shepherd (10 shared papers)Michael Gent (4 shared papers)Jacques Rouëssé (6 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Annals of Oncology (9 papers)European Journal of Cancer (6 papers)The Lancet (3 papers)JNCI Journal of the National Cancer Institute (3 papers)
- Partner nations
- CanadaUnited KingdomBelgium
In The Last Decade
V. Bramwell
66 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 108
- Internal Medicine 289
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 1.5k
- Cancer Research 677
- Cardiology and Cardiovascular Medicine 485
Countries citing papers authored by V. Bramwell
This map shows the geographic impact of V. Bramwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Bramwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Bramwell more than expected).
Fields of papers citing papers by V. Bramwell
This network shows the impact of papers produced by V. Bramwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Bramwell. The network helps show where V. Bramwell may publish in the future.
Co-authors
The 25 scholars most cited alongside V. Bramwell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 442 | |
| 2 | 1994 | 400 | |
| 3 | 2001 | 278 | |
| 4 | 1992 | 240 | |
| 5 | 1994 | 184 | |
| 6 | 1988 | 175 | |
| 7 | 2011 | 157 | |
| 8 | 1984 | 151 | |
| 9 | 2009 | 149 | |
| 10 | 1987 | 121 | |
| 11 | 1984 | 93 | |
| 12 | 1993 | 78 | |
| 13 | 2006 | 69 | |
| 14 | The role of chemotherapy in the management of non-metastatic operable extremity osteosarcoma. | 1997 | 54 |
| 15 | 1990 | 47 | |
| 16 | 2013 | 45 | |
| 17 | 1994 | 44 | |
| 18 | 2008 | 43 | |
| 19 | Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group. | 1993 | 40 |
| 20 | 2004 | 39 |
About V. Bramwell
V. Bramwell is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 66 papers that have together received 3.4k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (30 papers), Vascular Tumors and Angiosarcomas (17 papers), Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (11 papers), Cancer therapeutics and mechanisms (5 papers), Cardiac tumors and thrombi (4 papers), HER2/EGFR in Cancer Research (4 papers) and Estrogen and related hormone effects (4 papers). The work is most often cited by research in Internal Medicine (289 citations), Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.5k citations), Cancer Research (677 citations) and Cardiology and Cardiovascular Medicine (485 citations). V. Bramwell has collaborated with scholars based in Canada, United Kingdom and Belgium. Frequent co-authors include Mark N. Levine, Kathleen I. Pritchard, Armando Santoro, J. Buesa, David Warr, Lois E. Shepherd, Michael Gent, Jacques Rouëssé, Andrew Arnold and B. Findlay. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, The Lancet and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.